Ding QR - Search Results

1

Derivation and applications of human hepatocyte-like cells.

Li S, Huang SQ, Zhao YX, Ding YJ, Ma DJ, Ding QR. Li S, et al. Among authors: ding yj, ding qr. World J Stem Cells. 2019 Aug 26;11(8):535-547. doi: 10.4252/wjsc.v11.i8.535. World J Stem Cells. 2019. PMID: 31523372 Free PMC article. Review.

2

Use of genome editing tools in human stem cell-based disease modeling and precision medicine.

Wei YD, Li S, Liu GG, Zhang YX, Ding QR. Wei YD, et al. Among authors: ding qr. Yi Chuan. 2015 Oct;37(10):983-91. doi: 10.16288/j.yczz.15-239. Yi Chuan. 2015. PMID: 26496750 Review.

3

[Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].

Liu GG, Li S, Wei YD, Zhang YX, Ding QR. Liu GG, et al. Among authors: ding qr. Yi Chuan. 2015 Nov;37(11):1167-73. doi: 10.16288/j.yczz.15-240. Yi Chuan. 2015. PMID: 26582531 Chinese.

4

Applications of genome editing tools in precision medicine research.

Li S, Yang YY, Qiu Y, Chen Y, Xu LW, Ding QR. Li S, et al. Among authors: ding qr. Yi Chuan. 2017 Mar 20;39(3):177-188. doi: 10.16288/j.yczz.16-395. Yi Chuan. 2017. PMID: 28420614 Review.

5

Genetic and Chemical Screenings Identify HDAC3 as a Key Regulator in Hepatic Differentiation of Human Pluripotent Stem Cells.

Li S, Li M, Liu X, Yang Y, Wei Y, Chen Y, Qiu Y, Zhou T, Feng Z, Ma D, Fang J, Ying H, Wang H, Musunuru K, Shao Z, Zhao Y, Ding Q. Li S, et al. Stem Cell Reports. 2018 Jul 10;11(1):22-31. doi: 10.1016/j.stemcr.2018.05.001. Epub 2018 May 31. Stem Cell Reports. 2018. PMID: 29861165 Free PMC article.

6

Identification of small-molecule ion channel modulators in C. elegans channelopathy models.

Jiang Q, Li K, Lu WJ, Li S, Chen X, Liu XJ, Yuan J, Ding Q, Lan F, Cai SQ. Jiang Q, et al. Nat Commun. 2018 Sep 26;9(1):3941. doi: 10.1038/s41467-018-06514-5. Nat Commun. 2018. PMID: 30258187 Free PMC article.

7

Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissue.

Qiu Y, Sun Y, Xu D, Yang Y, Liu X, Wei Y, Chen Y, Feng Z, Li S, Reyad-Ul Ferdous M, Zhao Y, Xu H, Lao Y, Ding Q. Qiu Y, et al. EBioMedicine. 2018 Nov;37:344-355. doi: 10.1016/j.ebiom.2018.10.019. Epub 2018 Oct 20. EBioMedicine. 2018. PMID: 30348622 Free PMC article.

8

Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes.

Zhao Y, Feng Z, Zhang Y, Sun Y, Chen Y, Liu X, Li S, Zhou T, Chen L, Wei Y, Ma D, Lui KO, Ying H, Chen Y, Ding Q. Zhao Y, et al. Cell Rep. 2019 Jan 22;26(4):884-892.e4. doi: 10.1016/j.celrep.2018.12.100. Cell Rep. 2019. PMID: 30673611 Free article.

9

Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-κB and JNK signaling pathways.

Ding LY, Liang LZ, Zhao YX, Yang YN, Liu F, Ding QR, Luo LJ. Ding LY, et al. Among authors: ding qr. Oral Dis. 2019 Oct;25(7):1789-1797. doi: 10.1111/odi.13153. Epub 2019 Jul 28. Oral Dis. 2019. PMID: 31283861

10

Type 2 Diabetes Variants in the SLC16A11 Coding Region Are Not Loss-of-Function Mutations.

Zhao Y, Feng Z, Ding Q. Zhao Y, et al. Cell Rep. 2019 Oct 15;29(3):781-784. doi: 10.1016/j.celrep.2019.09.022. Cell Rep. 2019. PMID: 31618644 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters